Trino Therapeutics Ltd.
Fern-derived treatment for inflammatory bowel disease
This article was originally published in Start Up
Executive Summary
Ferns have never been economically important plants, but they have been used by native healers around the globe. Trinity College spin-out Trino Therapeutics Ltd. aims to develop new treatments for inflammatory bowel disease based on compounds with an indane skeleton, a six-member ring joined to a five-member ring, from extracts of a fern of the Onychium species used in traditional Taiwanese medicine.
You may also be interested in...
A Closer Look: Hutchison MediTech TCM Deal With Nestle Reaches Into Pharma Development
A new joint venture between Nestle Health Science and Chi-Med covering nutritional and medicinal products derived from botanical plants also includes Phase III drug HMPL-004, ending the Chinese R&D firm’s long search for a partner.
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.